Results

Total Results: 2,231 records

Showing results for "disease".

441. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
     February 15, 2017 - included: (a) clarifying the screening tools to be considered and how International Classification of Diseases … Global status report on noncommunicable diseases 2014. … Centers for Disease Control and Prevention (CDC). Heart Disease Facts, 2015. … Food and Drug Administration GI Gastrointestinal ICD International Classification of Diseases KQ … Duloxetine Yes Hypertension Levomilnacipran4 Yes Cerebrovascular disease, Cardiovascular disease

442. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - National Digestive Diseases Information Clearinghouse (NDDIC). Irritable bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2013 Sep … Available: http://www.mayoclinic.org/diseases- conditions/irritable-bowel- syndrome/basics/definition … /irritable-bowel-syndrome/basics/definition/CON-20024578 http://www.mayoclinic.org/diseases-conditions … /irritable-bowel-syndrome/basics/definition/CON-20024578 http://www.mayoclinic.org/diseases-conditions

443. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - insulin secretion by pancreatic beta cells, leading to chronic hyperglycemia and associated long-term disease … Long-term complications of diabetes include microvascular disease, such as retinopathy and blindness, … neuropathy, nephropathy, and end-stage kidney disease. … In addition, the death rate from cardiovascular disease in adults with type 2 diabetes is two to four … Diabetes Care 2006; 29(6):1263-1268. 2 National Institute of Diabetes and Digestive and Kidney Diseases

444. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - Periods of remission are common, particularly in younger patients and those with milder disease. … We evaluated RLS symptom severity and outcome, patient-reported sleep quality, and disease-specific … Mean RLS disease duration was 12 years. … No RCTs assessed patients with mild or moderate disease, and few lasted longer than 6 months. … Severity of disease • Clinical trials include patients with moderate to very severe disease typically

445. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
     January 01, 2009 - prevalence in study population different than community Prevalence of disease (for diagnostic studies … Finally, evaluate the prevalence of the disease in diagnostic test studies. … If the disease prevalence is markedly different than in the community, then applicability is reduced. … This is especially true in diseases that afflict patients with lower compliance rates such as abusers … In this example, we focus on the age of patients with a disease.

446. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
     January 01, 2009 - prevalence in study population different than community Prevalence of disease (for diagnostic studies … Finally, evaluate the prevalence of the disease in diagnostic test studies. … If the disease prevalence is markedly different than in the community, then applicability is reduced. … This is especially true in diseases that afflict patients with lower compliance rates such as abusers … In this example, we focus on the age of patients with a disease.

447. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - Morbidity and Mortality Obesity is a risk factor for chronic conditions including cardiovascular disease … , diabetes, cardiovascular disease, cancer, liver disease, or death … Obesity-related clinical outcomes • Mortality • Cancer • Cardiovascular disease • Sub-fertility … • Diabetes • Degenerative joint disease • Liver disease • Quality of life Adverse effects … Multiple risk factors for cardiovascular disease and diabetes mellitus.

448. EHC Protocol - Allocation of Scarce Resources During Pandemics: Strategies for Policy Makers: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/scarce-resources-protocol.pdf
     January 01, 2013 - tiab] OR "emergency planning" OR "emergency preparedness" OR mass casualt* OR pandemic OR epidemic OR disease … SCIENCE CATEGORIES: ( PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH OR MEDICAL INFORMATICS OR INFECTIOUS DISEASES … OR "emergency planning" OR "emergency preparedness" OR "mass casualt*" OR pandemic OR epidemic OR "disease … OR "emergency planning" OR "emergency preparedness" OR "mass casualt*" OR pandemic OR epidemic OR "disease … outbreak*")):ti,ab,kw OR MeSH descriptor: [Disasters] explode all trees OR MeSH descriptor: [Disease

449. PowerPoint Presentation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/krishnan_ahrq-mcda-presentation.pdf
     August 27, 2012 - Chronic obstructive pulmonary disease (COPD) as a key health condition. 2. … Analytic hierarchy process to establish priorities. 2 Chronic Obstructive Pulmonary Disease … common lung disorder • 24,000,000 persons – 3rd leading cause of death • Deaths rising • Heart disease … hospital readmissions – $49.9 billion / yr NHLBI Chartbook 3 Chronic Obstructive Pulmonary Disease

450. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - The condition is associated with the skin disease psoriasis, but not all people with psoriasis will … Additionally, PsA may predate the development of skin disease leading to some diagnostic uncertainty … Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … KQ1: For patients with psoriatic arthritis, do drug therapies differ in their ability to reduce disease … activity, and concurrently, "disease activity" was removed from KQ2 and replaced with "patient reported

451. Asthma-Immunotherapy-2011 Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
     January 01, 2011 - if the articles examined incidence and risk factors for the same disease. … Links between passive smoking and disease: a best-evidence synthesis. … Interpretation of genetic association studies in complex disease. … Source of measure incidence/prevalence of chronic diseases. … ) (define importance of severity specific for the nature of the disease).

452. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
     September 01, 2011 - Layout 1 Background Gastroesophageal reflux disease (GERD) is one of the most common health conditions … GERD continues to be an important disease in terms of both cost and public health. … The impact of GERD treatment may be limited in diseases or symptoms with complex etiologies, such as … Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease. … Management Strategies for Gastroesophageal Reflux Disease: An Update.

453. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - These include clinically relevant definitions of disease, disease severity and disease resolution. … Severe underlying disease, acid suppression, and age are indicated as risk factors. … Does effectiveness vary by disease severity or strain? b. … diverse perspectives, including methodological/research expertise, clinical experience (from infectious diseases … concomitant antibiotics, role of carriers, reducing antibiotics by X amount, age, severity of underlying diseases

454. Cancer-Pancreas Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
     September 01, 2014 - United States, about 46,000 people received a diagnosis of pancreatic cancer and 40,000 died of the disease … cancer.1 About 10 percent of patients with pancreatic cancer have a positive family history of the disease … As a result, patients often present with advanced stage disease when weight loss, jaundice, and severe … Once pancreatic adenocarcinoma is diagnosed, staging the disease is critical and is the key determinant … chance of their disease actually being resectable

455. chronic-fatigue-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-fatigue_research-protocol.pdf
     May 01, 2014 - altered immune and autonomic responses.1,2,7 The variable symptomatology and lack of an identifiable disease … measurement have challenged researchers and clinicians in their attempts to better understand the disease … The burden of disease and economic impact from both medical and societal costs may be in the billions … This topic was nominated by the Office of Disease Prevention (ODP) at the National Institutes of Health … Myalgic Encephalomyelitis and Postviral Fatigue States: The saga of Royal Free disease. 1st ed.

456. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 - and exercise, glycemic control using a variety of medications, and lowering co-morbid cardiovascular disease … improved glycemic control reduces microvascular complications,1, 5-8 but the impact on cardiovascular disease … and events, peripheral vascular disease and amputations, and stroke) and microvascular complications … National Center for Chronic Disease Prevention and Health Promotion. … National Center for Chronic Disease Prevention and Health Promotion.

457. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - Background and Objectives for the Systematic Review Clostridium difficile associated disease (CDAD … Does effectiveness vary by disease severity or strain? b. … United States Centers for disease Control and Prevention. … Emerging therapies in the treatment of Clostridium difficile-associated disease. … Current and future treatment modalities for Clostridium difficile-associated disease.

458. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - (The therapy has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment stems from the observation that inflammatory bowel diseases are rare … The rationale for this treatment stems from the observation that inflammatory bowel diseases are rare … and other inflammatory bowel diseases. 8 The manufacturer does not appear to intend to seek FDA … Bethesda (MD): National Digestive Diseases Information Clearinghouse; [accessed 2011 Jun 6]. [4 p

459. Partial Breast Irradiation for Breast Cancer: Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
     August 09, 2021 - : new primary tumors have more favorable outcomes than true local disease recurrences. … frequency study" or "disease frequency analysis" or "disease frequency survey" or crossover or "cross-over … frequency study" or "disease frequency analysis" or "disease frequency survey" or crossover or "cross-over … frequency study” or 26 “disease frequency analysis” or “disease frequency survey” or crossover … frequency study" or "disease frequency analysis" or "disease frequency survey" or crossover or "cross-over

460. Ch 10-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
     January 01, 2011 - Disease risk scores estimate the probability or rate of disease occurrence as a function of the covariates … become more common in recent years include using summary variables, such as propensity scores and disease … Disease Risk Scores The disease risk score (DRS) is an alternative to the propensity score.36-37 Like … It is useful for summarizing disease risk and assessing effect modification by disease risk. … Use of disease risk scores in pharmacoepidemiologic studies.